Home › Mielofibrosi › Massachusetts › Boston
Studi clinici su Mielofibrosi a Boston, MA
12 studi su Mielofibrosi cercano partecipanti presso sedi a Boston e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
In reclutamentoFase 1/2
- Massachusetts General Hospital, Boston
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
In reclutamentoFase 3
- Tufts Medical Center, Boston
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
In reclutamentoFase 1
- Massachusetts General Hospital, Boston
- Dana Farber Cancer Institute, Boston
A Study of Ruxolitinib in Combination With Ulixertinib in People With Myelofibrosis
In reclutamentoFase 1/2
- Massachusetts General Hospital (Data Collection Only), Boston
A Vaccine (CMV-MVA Triplex Vaccine) for the Enhancement of CMV-Specific Immunity and the Prevention of CMV Viremia in Patients Undergoing Haploidentical Hematopoietic Stem Cell Transplant
In reclutamentoFase 1Volontari sani benvenuti
- Brigham and Women's Hospital, Boston
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
In reclutamentoFase 1
- Massachusetts General Hospital, Boston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
In reclutamentoFase 1
- Dana Farber Cancer Institute, Boston
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
In reclutamentoFase 1
- Dana Farber Cancer Institute, Boston
Momelotinib During and After HCT in Myelofibrosis
In reclutamentoFase 1
- Massachusetts General Hospital, Boston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
In reclutamentoFase 2
- Dana-Farber Cancer Institute, Boston
CMV-MVA Triplex Vaccination in HLA-Matched Related Stem Cell Donors for the Prevention of CMV Infection in Patients Undergoing Hematopoietic Stem Cell Transplant
In reclutamentoFase 2Volontari sani benvenuti
- DFCI/BWH Brigham and Women's Hospital, Boston
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
In reclutamentoFase 3
- Dana Farber Cancer Institute, Boston
Studi su Mielofibrosi in altre città
- Houston, TX19 studi
- New York City, NY18 studi
- Durham, NC12 studi
- Columbus, OH11 studi
- Seattle, WA11 studi
- Salt Lake City, UT10 studi
- Miami, FL10 studi
- Nashville, TN9 studi
- Cleveland, OH9 studi
- Tampa, FL9 studi
- Atlanta, GA9 studi
- Baldwin Park, CA9 studi
Altri studi a Boston
- Cancro al seno111 studi
- Cancro del polmone non a piccole cellule90 studi
- Cancro (tutti i tipi)86 studi
- Cancro colorettale63 studi
- Cancro metastatico63 studi
- Cancro ai polmoni62 studi
- Cancro ovarico61 studi
- Cancro alla prostata59 studi
- Depressione52 studi
- Cancro dell'endometrio50 studi
- Insufficienza cardiaca44 studi
- Leucemia mieloide acuta44 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.